Clinical trial
Evaluation of Safety and Tolerability of Libella Gene Therapy (LGT) for Alzheimer's Disease: AAV- hTERT
NCT04133454 is registered in ClinicalTrials.gov with Libella Gene Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety and Tolerability of Libella Gene Therapy (LGT) for Alzheimer's Disease: AAV- hTERT
- Lead sponsor
- Libella Gene Therapeutics
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- October 10, 2019
- Completion date
- January 31, 2021
- Enrollment
- 5 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.